Adipotide / FTTP 5mg is a groundbreaking research peptide designed for targeted fat cell reduction. This innovative peptide works by binding to specific blood vessels that supply blood to fat cells (adipose tissue), potentially causing fat cell apoptosis, or programmed cell death. By disrupting the blood flow to fat cells, Adipotide may directly contribute to fat loss and body composition improvements, making it a powerful tool for advanced metabolic and fat loss research.

Key research applications include:

• Targeted Fat Cell Reduction: Adipotide specifically targets the vascular network of fat cells, leading to reduced blood supply, which can trigger fat cell death and support fat mass reduction.

• Visceral Fat Loss: Studies are exploring its potential to target visceral fat, which is often associated with metabolic disorders and health risks like heart disease and diabetes.

• Improved Metabolic Markers: Adipotide has the potential to positively impact metabolic markers, supporting research in areas like glucose metabolism, insulin sensitivity, and overall metabolic health.

• Body Composition Optimization: By promoting fat loss without affecting lean tissue, Adipotide is being studied for its role in improving body composition and metabolic efficiency.

For Laboratory Research Use Only
Adipotide / FTTP 5mg is strictly for in-vitro research applications and is not intended for human or animal consumption. Ensure proper handling and adhere to research protocols when using this peptide.